Diseases & Disorders
(G9XC)
AMERICAN SOCIETY OF CYTOPATHOLOGY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$1.6M
Total Revenue
$1.6M
Total Expenses
N/A
Net Assets
6
Employees
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$154K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.6M | $1.6M | N/A | — | 6 |
| 2022 | $1.3M | $1.3M | N/A | — | 5 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.